Has Seema Khosla, MD received payments from drug or device companies?

Yes. Drug and device makers reported $43,080 in general payments to Seema Khosla, MD across 66 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Seema Khosla, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Seema Khosla, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Seema Khosla, MD

Pulmonary Disease · Fargo, NDNPI 1659462455

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Jazz Pharmaceuticals Inc. accounts for 62.7% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $23,667, more than ten times the $190 reported in 2019. Among pulmonary disease clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$43,080in general payments, 2019–2025

Across 66 payments — averaging $652.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Jazz Pharmaceuticals Inc.$27K
Lilly USA, LLC$8K
Eisai Inc.$6K
Philips North America LLC$783
Ensodata, Inc.$575
Harmony Biosciences LLC$168
plus $224 from 4 others

What the payments were for

Consulting fees$23,54355%
Speaking & faculty fees$14,29533%
Travel & lodging$3,1107%
Food & beverage$2,1335%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Jazz Pharmaceuticals Inc.	36	$26,992
Lilly USA, LLC	10	$8,309
Eisai Inc.	2	$6,030
Philips North America LLC	2	$783
Ensodata, Inc.	2	$575
Harmony Biosciences LLC	6	$168
3b Medical, Inc.	2	$94
Avadel CNS Pharmaceuticals, LLC	3	$73
Axsome Therapeutics, Inc.	2	$35
Idorsia Pharmaceuticals US Inc	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XYWAV$16,184
ZEPBOUND$7,425
Dayvigo$6,030
(7999) SRC Undivided$668
XYREM$333
NightBalance Und$115
Mask$115

How this compares

$43,080 in reported general payments places this provider in the 95th percentile of 31 pulmonary disease providers in North Dakota.

See all pulmonary disease providers in North Dakota →

Medicare billing

Part B allowed, 2024

$21,487

Medicare patients

173

Services billed

203

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Armodafinil	21	$365
Clonazepam	12	$308
Zolpidem Tartrate ErZolpidem Tartrate	14	$169
Zolpidem Tartrate	17	$101

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Fargo

Venkatkiran KanchustambhamFargo$14K
Michael TalalaevFargo$8K
Muhammad Asad FaruqiFargo$8K
Craig BackousFargo$7K
Kara JohnsonFargo$4K
Weston BowkerFargo$4K
Praveen JinnurFargo$3K
Karol KremensFargo$2K
Ajay AggarwalFargo$560
Namratta GhatehordeFargo$96

See the full list for North Dakota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →